首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1267篇
  免费   87篇
  国内免费   7篇
耳鼻咽喉   3篇
儿科学   63篇
妇产科学   10篇
基础医学   115篇
口腔科学   31篇
临床医学   196篇
内科学   304篇
皮肤病学   13篇
神经病学   48篇
特种医学   300篇
外科学   120篇
综合类   22篇
预防医学   42篇
眼科学   7篇
药学   46篇
中国医学   5篇
肿瘤学   36篇
  2023年   9篇
  2021年   16篇
  2020年   6篇
  2019年   15篇
  2018年   30篇
  2017年   12篇
  2016年   18篇
  2015年   21篇
  2014年   28篇
  2013年   25篇
  2012年   25篇
  2011年   22篇
  2010年   44篇
  2009年   65篇
  2008年   40篇
  2007年   27篇
  2006年   34篇
  2005年   16篇
  2004年   21篇
  2003年   28篇
  2002年   25篇
  2001年   20篇
  2000年   22篇
  1999年   31篇
  1998年   56篇
  1997年   52篇
  1996年   68篇
  1995年   50篇
  1994年   46篇
  1993年   49篇
  1992年   23篇
  1991年   23篇
  1990年   21篇
  1989年   46篇
  1988年   36篇
  1987年   42篇
  1986年   44篇
  1985年   38篇
  1984年   23篇
  1983年   22篇
  1982年   24篇
  1981年   17篇
  1980年   8篇
  1979年   4篇
  1978年   6篇
  1977年   18篇
  1976年   12篇
  1975年   16篇
  1968年   2篇
  1966年   4篇
排序方式: 共有1361条查询结果,搜索用时 234 毫秒
1.
2.
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma.  相似文献   
3.
4.
5.
6.
7.
8.
9.
Liver transplantation: MR angiography with surgical validation   总被引:6,自引:0,他引:6  
Thirty patients (mean age, 45 years) were evaluated with magnetic resonance (MR) angiography before liver transplantation to assess the accuracy of MR angiography. A series of breath-hold, two-dimensional images were acquired and subsequently processed to form three-dimensional projection angiograms. Graphic information on blood flow in the portal vein was acquired by using presaturation bolus tracking. Correlative duplex ultrasound (US) was performed in 28 patients, and surgical or autopsy correlation was available in all cases. MR angiography demonstrated patency of the portal vein in 26 (96%) of 27 patients, made possible the diagnosis of portal venous occlusion in three of three patients, depicted reversed portal flow in one patient, and provided clear delineation of the extent of varices and specific portosystemic collateral vessels. When duplex US was successful, there was full agreement with MR angiographic results in assessing portal vein patency and flow direction. All of the MR findings were corroborated at surgical exploration or autopsy. The authors conclude that MR angiography is very accurate in the portal system and is valuable in preoperative assessment for liver transplantation.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号